Compare DSP Nifty Healthcare Index Fund vs UTI Healthcare Fund
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 0.89 | 2.26 |
NAV | ₹10.30 | ₹283.00 |
Fund Started | 02 Jun 2025 | 01 Aug 2005 |
Fund Size | ₹14.43 Cr | ₹1126.13 Cr |
Exit Load | - | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
0.89
2.26
NAV
₹10.30
₹283.00
Fund Started
02 Jun 2025
01 Aug 2005
Fund Size
₹14.43 Cr
₹1126.13 Cr
Exit Load
-
Exit load of 1% if redeemed within 30 days.
1 Year | - | -1.09% |
3 Year | - | 24.09% |
5 Year | - | 15.29% |
1 Year
-
-1.09%
3 Year
-
24.09%
5 Year
-
15.29%
Equity | 99.72% | 98.75% |
Cash | 0.28% | 1.24% |
Equity
99.72%
98.75%
Cash
0.28%
1.24%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 19.16% |
Max Healthcare Institute Ltd. | 8.58% |
Cipla Ltd. | 8.55% |
Divi's Laboratories Ltd. | 8.17% |
Dr. Reddy's Laboratories Ltd. | 7.61% |
Apollo Hospitals Enterprise Ltd. | 7.36% |
Lupin Ltd. | 5.00% |
Fortis Healthcare Ltd. | 4.76% |
Laurus Labs Ltd. | 3.98% |
Torrent Pharmaceuticals Ltd. | 3.86% |
Sun Pharmaceutical Industries Ltd. | 9.76% |
Ajanta Pharma Ltd. | 6.48% |
Lupin Ltd. | 5.91% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Dr. Reddy's Laboratories Ltd. | 3.74% |
Gland Pharma Ltd. | 3.46% |
Apollo Hospitals Enterprise Ltd. | 3.45% |
Alkem Laboratories Ltd. | 3.43% |
Procter & Gamble Health Ltd. | 3.41% |
Cipla Ltd. | 3.40% |
Name | Anil Ghelani | Kamal Gada |
Start Date | 24 Nov 2025 | 02 May 2022 |
Name
Anil Ghelani
Kamal Gada
Start Date
24 Nov 2025
02 May 2022
Description | The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 02 Jun 2025 | 01 Aug 2005 |
Description
The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
02 Jun 2025
01 Aug 2005